🇺🇸 olanzapine + fluoxetine in United States

29 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Completed Suicide — 6 reports (20.69%)
  2. Dyspnoea — 3 reports (10.34%)
  3. Headache — 3 reports (10.34%)
  4. Suicidal Ideation — 3 reports (10.34%)
  5. Vomiting — 3 reports (10.34%)
  6. Weight Increased — 3 reports (10.34%)
  7. Asthenia — 2 reports (6.9%)
  8. Blood Pressure Increased — 2 reports (6.9%)
  9. Condition Aggravated — 2 reports (6.9%)
  10. Diabetes Mellitus — 2 reports (6.9%)

Source database →

Other Psychiatry approved in United States

Frequently asked questions

Is olanzapine + fluoxetine approved in United States?

olanzapine + fluoxetine does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for olanzapine + fluoxetine in United States?

University of Florida is the originator. The local marketing authorisation holder may differ — check the official source linked above.